secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001654954-23-001023
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv FY2022 net income $1.0M, up from prior loss; revenue $19.4M down 3.5%
--------------------------------------------------------------------------------

- Revenue for FY ended Oct 31, 2022: ~$19.4M, down ~$0.7M from prior year.
- Net income ~$1.0M vs net loss in FY2021; improvement of ~$3.0M.
- Prior year included $5.2M accounts receivable provision and $2.0M PPP loan forgiveness.
- CEO cites strengthening in continental US and European markets; pursuing strategic acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423001023/0001654954-23-001023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423001023/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-001023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer